Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden · Delayed Price · Currency is SEK 3.340
+0.180 (5.70%)
Apr 30, 2026, 12:52 PM CET
Elicera Therapeutics AB Market Cap
Elicera Therapeutics AB has a market cap or net worth of 153.37 million as of April 30, 2026. Its market cap has increased by 6.94% in one year.
Market Cap
153.37M
Enterprise Value
135.51M
Revenue
10.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.34
Market Cap Chart
Since June 11, 2021, Elicera Therapeutics AB's market cap has increased from 122.65M to 153.37M, an increase of 25.05%. That is a compound annual growth rate of 4.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 162.11M | -36.02% |
| Dec 30, 2025 | 253.36M | 332.30% |
| Dec 30, 2024 | 58.61M | -35.03% |
| Dec 29, 2023 | 90.21M | 29.73% |
| Dec 30, 2022 | 69.53M | -29.98% |
| Dec 30, 2021 | 99.31M | -19.03% |
| Jun 11, 2021 | 122.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Initiator Pharma | 229.32M |
| Isofol Medical AB | 214.73M |
| Xbrane Biopharma AB | 206.05M |
| Xintela AB | 204.98M |
| Active Biotech AB | 163.44M |
| Diamyd Medical AB | 163.35M |
| AlzeCure Pharma AB | 158.58M |
| Alligator Bioscience AB | 136.93M |